634 related articles for article (PubMed ID: 19615546)
21. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
Li Y; Li Z; Lin HL; Chen XH; Li B
Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
[TBL] [Abstract][Full Text] [Related]
22. CD30(+) cutaneous lymphoma in association with atopic eczema.
Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R
Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373
[TBL] [Abstract][Full Text] [Related]
23. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.
Gjerdrum LM; Woetmann A; Odum N; Hother C; Henrik-Nielsen R; Gniadecki R; Ralfkiaer E
Eur J Haematol; 2008 Jun; 80(6):483-9. PubMed ID: 18331599
[TBL] [Abstract][Full Text] [Related]
24. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Kawano R; Suzumiya J; Utsunomiya A; Harada M; Kikuchi M
Br J Haematol; 2004 Jul; 126(1):81-4. PubMed ID: 15198736
[TBL] [Abstract][Full Text] [Related]
25. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.
Miyara M; Yoshioka Y; Kitoh A; Shima T; Wing K; Niwa A; Parizot C; Taflin C; Heike T; Valeyre D; Mathian A; Nakahata T; Yamaguchi T; Nomura T; Ono M; Amoura Z; Gorochov G; Sakaguchi S
Immunity; 2009 Jun; 30(6):899-911. PubMed ID: 19464196
[TBL] [Abstract][Full Text] [Related]
26. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
Ebert LM; Tan BS; Browning J; Svobodova S; Russell SE; Kirkpatrick N; Gedye C; Moss D; Ng SP; MacGregor D; Davis ID; Cebon J; Chen W
Cancer Res; 2008 Apr; 68(8):3001-9. PubMed ID: 18413770
[TBL] [Abstract][Full Text] [Related]
27. Decreased number of FoxP3+ regulatory T cells in preeclampsia.
Toldi G; Svec P; Vásárhelyi B; Mészáros G; Rigó J; Tulassay T; Treszl A
Acta Obstet Gynecol Scand; 2008; 87(11):1229-33. PubMed ID: 19016357
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
Rao V; Saunes M; Jørstad S; Moen T
Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
[TBL] [Abstract][Full Text] [Related]
29. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
[TBL] [Abstract][Full Text] [Related]
30. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
[TBL] [Abstract][Full Text] [Related]
31. The vast majority of lymphocytes infiltrating primary cutaneous melanoma express the CD27 costimulatory receptor: implications for melanoma progression.
Pepe CA; Ricci R; Cortelazzi C; Mori G; Zambito F; Campanini N; Aimi F; Santoro S; Lombardi M; Santini M; de Panfilis G
Eur J Dermatol; 2011; 21(2):178-83. PubMed ID: 21382782
[TBL] [Abstract][Full Text] [Related]
32. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
[No Abstract] [Full Text] [Related]
33. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
34. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
37. Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis.
Laetsch B; Hofbauer G; Kempf W; Burg G; Dummer R
Dermatology; 2005; 210(4):341-5. PubMed ID: 15942225
[TBL] [Abstract][Full Text] [Related]
38. Neuropilin-1 is not a marker of human Foxp3+ Treg.
Milpied P; Renand A; Bruneau J; Mendes-da-Cruz DA; Jacquelin S; Asnafi V; Rubio MT; MacIntyre E; Lepelletier Y; Hermine O
Eur J Immunol; 2009 Jun; 39(6):1466-71. PubMed ID: 19499532
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
